Biotechnology Stocks II Performance Guide: Fate Therapeutics, Inc. (FATE)
FATE has no dividends.
Table and Chart of FATE Performance
See what a $1,000 investment in FATE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| FATE Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $6.03 |
| End Date | Jul-26-2024 |
| End Price | $5.44 |
| # Prices | 121 |
| Min Date | May-31-2016 |
| Min Price | $1.53 |
| Max Date | Dec-31-2020 |
| Max Price | $90.93 |
| Total Return | -9.78% |
| Annualized Return | -1.02% |
| Current Value of $1,000 Purchase | $902 |
| Number Returns | 7,260 |
| Average Return | 338.53% |
| Number Profitable Returns | 4,712 |
| Percent Profitable Returns | 64.90% |
| Number Unprofitable Returns | 2,548 |
| Percent Unprofitable Returns | 35.10% |
| Profitable to Unprofitable Returns Ratio | 1.85 |
| FATE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $614,693,000 |
| Beta | 1.901 | Price to Sales | 10.33 |
| Earnings per Share | $-1.9200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 1.785 |
| PRICE DATA | |
| 52 Week High | $8.83 |
| 52 Week Low | $1.63 |
| Analyst Target Price | $6.79 |
| 50-Day Moving Average | $3.787 |
| 200-Day Moving Average | $4.322 |
| FINANCIAL DATA | |
| Revenue per Share | $0.065 |
| Revenue | $6,478,000 |
| Profit Margin | 0% |
| Return on Equity | -42.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
FATE Compare Returns with S&P 500
FATE Trendline Chart
FATE Moving Average Chart
FATE Stock Return Map - See Patterns of Gains and Losses
FATE Stock Returns/Purchase Dates